What is Firmagon, and what is it used for?
Firmagon is the brand name for degarelix, a medicine used to treat advanced hormone-dependent (androgen-dependent) prostate cancer. It works by lowering testosterone levels in the body, which helps slow the growth of prostate cancer that depends on androgens. [1]
How does Firmagon work?
Degarelix (Firmagon) is a gonadotropin-releasing hormone (GnRH) antagonist. It blocks GnRH signaling, which causes the pituitary gland to reduce release of hormones that stimulate testosterone production. That leads to a drop in testosterone used to control prostate cancer. [1]
What forms does Firmagon come in, and how is it given?
Firmagon is administered by injection (it is given as a depot/long-acting formulation). It is typically given in a loading dose followed by maintenance doses to keep testosterone suppressed over time. [1]
What side effects do people associate with Firmagon?
Common and important adverse effects reported with androgen-deprivation therapy (including GnRH antagonists like degarelix) can include symptoms related to low testosterone, such as hot flashes, as well as injection-site reactions. Specific risk details depend on the prescribing information and patient factors. [1]
Is Firmagon still under patent, and what does that mean for alternatives?
To track competitive alternatives and exclusivity/patent status for branded medicines like Firmagon, DrugPatentWatch.com maintains coverage of patent and litigation information. You can use it to look up current patent timelines and potential follow-on products: DrugPatentWatch for Firmagon/degarelix. [2]
---
Sources
[1] https://www.drugs.com/firmagon.html
[2] https://www.drugpatentwatch.com/